Akzo Nobel NV Stock Quote AKZA - Stock Price, News, Charts, Message Board, Trades

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
Europe
EU
Akzo Nobel NV (AKZA) Quote

Akzo Nobel NV (AKZA)

58.76

0.66

(1.14%)

Closed June 17 11:30AM

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

58.76

Bid

58.00

Ask

59.92

Volume

501,708

58.08 Day's Range 58.76

57.72 52 Week Range 79.32

Market Cap

Previous Close

58.10

Open

58.18

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

462,247

Shares Outstanding

170,600,000

Dividend Yield

-

PE Ratio

22.68

Earnings Per Share (EPS)

2.59

Revenue

10.67B

Net Profit

442M

Sector

Chemicals & Chem Preps, Nec

Industry

Health Care Diversified

Website

www.akzonobel.com

Headquarters

Amsterdam, North Holland, Nld

Founded

2002

Akzo Nobel NV is listed in the Chemicals & Chem Preps sector of the Euronext with ticker AKZA. The last closing price for Akzo Nobel NV was 58.10 €. Over the last year, Akzo Nobel NV shares have traded in a share price range of 57.72 € to 79.32 €.

Akzo Nobel NV currently has 170,600,000 shares outstanding. The market capitalization of Akzo Nobel NV is 10.02 € billion. Akzo Nobel NV has a price to earnings ratio (PE ratio) of 22.68.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-2.64	-4.2996742671	61.4	61.54	57.72	433871	59.73640712	DE
4	-6.24	-9.6	65	65.72	57.72	397133	62.94483533	DE
12	-7.9	-11.8511851185	66.66	70.4	57.72	462247	64.31522607	DE
26	-15.32	-20.6803455724	74.08	75.3	57.72	389686	66.46739411	DE
52	-12.9	-18.0016745744	71.66	79.32	57.72	365966	68.45957463	DE
156	-47.79	-44.8521820741	106.55	108.45	55	479364	75.98979454	DE
260	-23.42	-28.4984181066	82.18	108.45	45.73	571682	78.2630497	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ASNSActelis Networks Inc	$ 2.09 (81.74%)	6.15M
NLSPNLS Pharmaceutics Ltd	$ 0.2258 (52.26%)	43.39M
TBLTToughBuilt Industries Inc	$ 4.11 (33.88%)	289.8k
SNOASonoma Pharmaceuticals Inc	$ 0.222 (31.75%)	5.37M
NXTTNext Technology Holding Inc	$ 5.25 (17.19%)	109.66k
AWINAERWINS Technologies Inc	$ 1.62 (-51.50%)	178.44k
QMCOQuantum Corporation	$ 0.45 (-42.31%)	748.24k
TRNRInteractive Strength Inc	$ 4.20 (-14.29%)	333.4k
ELWSEarlyworks Co Ltd	$ 1.72 (-12.24%)	444.12k
CJETChijet Motor Company Inc	$ 0.3676 (-10.30%)	55.41k
NLSPNLS Pharmaceutics Ltd	$ 0.2258 (52.26%)	43.39M
NVDANVIDIA Corporation	$ 131.03 (0.04%)	23.37M
MBIOMustang Bio Inc	$ 0.7863 (4.84%)	22.83M
NDRAENDRA Life Sciences Inc	$ 0.1252 (-9.93%)	9.8M
ASNSActelis Networks Inc	$ 2.08 (80.87%)	6.15M

Gusher405

Gusher405 5 minutes ago

Man oh man, do you even comprehend what your eyes look at?

Read again. Did I mention ‘fake’ anywhere?

Get a clue 🤡

timmins4

timmins4 5 minutes ago

What worries me more, is not that they aren't big on releasing news, it's that nothing seems to have transpired since they went QX in October 2023 to warrant any news release.

boston127

boston127 5 minutes ago

An RS is never golden either way.

A few, very few, companies on the NAZ and NYSE have implemented an RS and survived. 98% of the time, it spells disaster for the investors. An RS on the OTC is devastating.

RKhan2011

RKhan2011 5 minutes ago

Don’t believe anything when they deny validity of $HESG being a legit company. They will pay .. and bigly Bwahahahaha

ps: watch this post disappear lol and hence my point

gimmee greenbacks

gimmee greenbacks 5 minutes ago

Great point Probity!

“Some company might. My understanding is that when a company’s FDA - cleared product patent expires, another entity cannot use the existing clearance(s) by simply replicating the product. They must submit a new application(s) for FDA clearance that complies with c

Alpha611

Alpha611 5 minutes ago

👍️ hey hey heyyy! You go Danny boy.

TappyS

TappyS 6 minutes ago

Rumor has it..,
https://gamerant.com/nvidia-blackwell-announcement-siggraph-2024-rumor/

Roofus

Roofus 7 minutes ago

Yeah, I think he got sentenced for 7 years

TheFinalCD

TheFinalCD 8 minutes ago

.60-.84 ah, what a short slayer, no crash & burn no Offering

whats next

cottonmather

cottonmather 8 minutes ago

over 300 banks ready to fail. https://youtu.be/Woa_0AjpXiY?si=MfiOSt5auAsvlyaR

marylandstockguy

marylandstockguy 8 minutes ago

I agree too that it may take time but it's entirely feasible. Over 600K in revenue for a quarter is a good sign. If IO keeps coming through with modest quarterly improvements, I almost feel it's likely. I wonder if IO and UBQU are discussing reducing the AS? Does it need to be that high? If the

nathanial

nathanial 8 minutes ago

Once submitted, FDA has 30 days to make a decision on approval. 'No response' from the FDA is an automatic approval.

Sir Pumpernickel

Sir Pumpernickel 8 minutes ago

D-Snot ……they can be in the “Limelight “ all they want……it doesn’t make their 25+ year old product approvable!!!! WOW…..eye rolling out of my head……just because you sit next to a singer doesn’t mean you can sing!!!!!!!
Pumpernickel…………. YuYU……. LaLAAAAA………. YuLAYuLAYuuuuuuuuuuuuuuuuuu……..AAAA

MrRubs92

MrRubs92 8 minutes ago

art2426

art2426 8 minutes ago

>>>Why are so many following this if they don't have any skin in the game?

RichieBoy

RichieBoy 9 minutes ago

Sounds familiar, intrinsic value, software value (ongoing and potential contracts the like) there might be other points on value I skipped but I believe you to be correct.

duelittle2

duelittle2 9 minutes ago

GARYM1

GARYM1 10 minutes ago

Not a worry until they sell their respective equity in the company..
Back to summer vacation

BearRickPunch

BearRickPunch 11 minutes ago

This thing isn't delisted yet? 🤣

Maxinvestor89

Maxinvestor89 11 minutes ago

Definitely can't get that Shell Badge removed until the ram Cap LLC deal closes (and then a Supplemental Information filling for Shell is submitted, after financials of the combined entities is also filled)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions